Clinical Trials Sponsored by Catabasis Pharmaceuticals

Total 19719 results

Catabasis Pharmaceuticals

Completed

Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy (PolarisDMD)

Muscular Dystrophy, Duchenne

United States, Canada, Australia, United Kingdom, Germany, Ireland, Israel, Sweden
Catabasis Pharmaceuticals

Completed

Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia (PATHWAYS I)

Dyslipidemia | Hypercholesterolemia | Hypertriglyceridemia

United States, Canada
Catabasis Pharmaceuticals

Completed

Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia

Hypertriglyceridemia | Hyperlipoproteinemia Type I | Lipoprotein Lipase Deficiency, Familial | Chylomicronemia, Familial

Canada
Catabasis Pharmaceuticals

Completed

Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia

Metabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | Hyperlipidemias | Hypertriglyceridemia

United States
Catabasis Pharmaceuticals

Completed

Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy (MoveDMD®)

Muscular Dystrophy, Duchenne

United States
Catabasis Pharmaceuticals

Completed

Study of Edasalonexent With Midazolam and Deflazacort in Healthy Subjects

Healthy

United States
Catabasis Pharmaceuticals

Completed

A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CAT-2054 in Healthy Subjects

Hypercholesterolemia

United States
Catabasis Pharmaceuticals

Terminated

An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy (GalaxyDMD)

Duchenne Muscular Dystrophy

United States, Canada, Australia, United Kingdom, Germany, Sweden
Catabasis Pharmaceuticals

Completed

A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003

Dyslipidemia

United States
Catabasis Pharmaceuticals

Completed

A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes

Type 2 Diabetes

United States
Catabasis Pharmaceuticals

Completed

A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia

Hypercholesterolemia

United States
Catabasis Pharmaceuticals

Completed

A Study of CAT-1004 Biomarkers in Healthy Subjects

Assessment of Mechanistic Blood Biomarkers in Healthy Humans

United States
Catabasis Pharmaceuticals

Completed

Safety, Tolerability, and Pharmacokinetic Study of CAT-1004 in Healthy Adult Volunteers

Healthy

United States
Catalysis SL

Not yet recruiting

Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours

Sarcoma | Advanced Solid Tumor | Advanced Cancer | Pediatric Cancer | Lymphoma, Hodgkin | Central Nervous System Tumor | Germ Cell Tumor

Honduras
Catalysis SL

Completed

Evaluation of Obex® in Overweight and Obesity

Overweight and Obesity

Cuba
Catalysis SL

Completed

Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal

Papillomavirus Infections | Papilloma Viral Infection | Esophageal Viral Wart | Esophageal Verrucous Carcinoma

Cuba
Catalysis SL

Completed

Effects of Obex in Overweight and Obese Patients

Obesity | Overweight

Cuba
Catalysis SL

Completed

Glizigen-Viudid-External Anogenital Warts in Children and Adolescents

External Anogenital Warts

Cuba
Catalysis SL

Completed

Diamel in the Treatment of Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Cuba
Catalysis SL

Completed

Melanil in the Treatment of Melasma

Melasma

Cuba
Catalysis SL

Completed

Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

Cuba
Catalysis SL

Completed

Diamel in the Treatment of Metabolic Syndrome

Metabolic Syndrome

Cuba
Catalysis SL

Completed

Efficacy of Folrex in the Superior Extremity Rehabilitation After Acute Stroke

Stroke

Cuba
Catalysis SL

Completed

Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children

Atopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis and Related Conditions | Atopic Dermatitis \(AD\)

Serbia
Catalysis SL

Completed

Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma

Digestive System Diseases | Endocrine System Diseases | Digestive System Neoplasms | Endocrine Gland Neoplasms | Pancreatic Neoplasms | Pancreatic Cancer | Pancreatic Diseases | Advanced Cancer | Adenocarcinoma of the Pancreas

Cuba
Catalysis SL

Completed

Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip

Respiratory Tract Infections | Covid19 | SARS-CoV2 Infection | COVID-19 Pneumonia | COVID-19 Respiratory Infection | Viral Infection | Infection, Coronavirus

Kazakhstan
Catalysis SL

Completed

Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma.

Cervical Carcinoma Stage II | Cervical Carcinoma Stage III | Cervical Carcinoma Stage IV | Endometrial Adenocarcinoma Stage II | Endometrial Adenocarcinoma Stage III | Endometrial Adenocarcinoma Stage IV

Cuba
Catalysis SL

Completed

Oncoxin® and Quality of Life in Cancer Patients

Non-small Cell Lung Cancer Stage III | Gastric Cancer Stage III | Gastric Cancer Stage II | Non-small Cell Lung Cancer Stage II

Kazakhstan, Russian Federation
Catalysis SL

Completed

Evaluation of Oncoxin-Viusid® in Prostate Cancer

Prostate Cancer

Cuba
Catalysis SL

Completed

Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.

Mucositis Oral

Russian Federation
Catalysis SL

Completed

Evaluation of DIAMEL® Combined With Insulin in Diabetic Foot Ulcer

Diabetes Mellitus, Type 2 | Diabetic Foot | Diabetic Foot Ulcer

Cuba
Catalysis SL

Completed

Evaluation of Ocoxin®-Viusid® in Breast Cancer

Breast Cancer | Breast Carcinoma | Adriamycin Toxicity | Cyclosporine Toxicity

Cuba
Catalysis SL

Completed

Renalof in the Treatment of Elderly Patients With Gallstones

Cholelithiasis

Cuba
Catalysis SL

Completed

Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis C

Chronic Hepatitis C

Cuba
Catalysis SL

Completed

Efficacy of Nutritional Supplement VIUSID/ALZER in Patients With Parkinson's Disease

Parkinson's Disease

Cuba
Catalysis SL

Completed

Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic Disease

Breast Fibrocystic Disease

Cuba
Catalysis SL

Completed

Cicatrix Cream in Post Surgical Scars and Epidermic Burn

Post Surgical Scars | Epidermic Burn

Cuba
Catalysis SL

Completed

Retorna Facial Cream in the Treatment of Facial Wrinkles

Facial Wrinkles

Cuba
Catalysis SL

Completed

Renalof in the Dissolution of Renal Calculi in Patients With Recurrent Calcic Lithiasis

Recurrent Calcic Urolithiasis

Cuba
Catalysis SL

Recruiting

Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions

Neoplasms | Carcinoma | Neoplasia; Intraepithelial, Cervix | Glandular Neoplasms | Epithelial Neoplasm

Cuba
Catalysis SL

Completed

Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma

Gastrointestinal Neoplasms | Colonic Diseases | Intestinal Neoplasms | Rectal Diseases | Colorectal Neoplasm | Digestive System Neoplasm | Digestive System Disease | Gastrointestinal Disease | Intestinal Disease

Cuba
Catalysis SL

Completed

Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction

Gastrointestinal Neoplasms | Stomach Diseases | Head and Neck Neoplasms | Esophageal Neoplasms | Esophageal Diseases | Digestive System Neoplasm | Digestive System Disease | Gastrointestinal Disease | Stomach Neoplasm | Esophagogastric Junction Disorder

Cuba
Catalysis SL

Completed

The Effectiveness of Spermotrend Food Supplement in the Treatment of Male Infertility

Benign Prostatic Hyperplasia | Male Infertility | Spermatogenesis and Semen Disorders

Nicaragua
Catalysis SL

Completed

Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer

Urogenital Neoplasms | Carcinoma | Neoplasms, Glandular and Epithelial | Endocrine System Diseases | Ovarian Diseases | Adnexal Diseases | Gonadal Disorders | Genital Diseases, Female | Ovarian Neoplasm | Female Urogenital Diseases | Endocrine Gland Neoplasm | Female Urogenital Diseases and Pregnancy Complications and other conditions

Cuba
Catalysis SL

Completed

Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19

Covid19 | Respiratory Disease | Supportive Care | Immune System | Immunomodulator | Antiseptic

Bulgaria
Catalysis SL

Completed

Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19

Liver Diseases | Covid-19 | Diabete Mellitus | Pulmonary Disease | Sars-CoV2 | Renal Disease | Cardiopathy

Ecuador
Catalysis SL

Completed

Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract

Kidney Calculi | Kidney Injury | Urolithiasis | Ureteral Calculi | Ureteral Obstruction | Renal Disease | Renal Stone | Ureteral Injury | Renal Injury | Urolithiasis, Calcium Oxalate | Urolithiasis; Lower Urinary Tract

Nicaragua
Catalysis SL

Completed

Alzer® and Diamel® to Prevent Severe Diabetes Macular Edema

Diabetic Macular Edema

Cuba
Catalysis SL

Completed

Evaluation of Oncoxin-Viusid® in Head and Neck Cancer

Head Cancer Neck

Cuba
Catalysis SL

Completed

Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma

Cutaneous Melanoma, Stage II | Cutaneous Melanoma, Stage III | Malignant Cutaneous Melanoma

Cuba

Clinical Trials Sponsored by Catabasis Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations